Chemfab Alkalis Future Growth
Future criteria checks 0/6
Wir verfügen derzeit nicht über ausreichende Analystenabdeckung, um Wachstum und Umsatz für Chemfab Alkalis zu prognostizieren.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Chemicals earnings growth | 19.7% |
Revenue growth rate | n/a |
Future return on equity | n/a |
Analyst coverage | None |
Last updated | n/a |
Recent future growth updates
No updates
Recent updates
Market Might Still Lack Some Conviction On Chemfab Alkalis Limited (NSE:CHEMFAB) Even After 30% Share Price Boost
Feb 23Do Chemfab Alkalis' (NSE:CHEMFAB) Earnings Warrant Your Attention?
Jul 18Under The Bonnet, Chemfab Alkalis' (NSE:CHEMFAB) Returns Look Impressive
Feb 11Why We Like The Returns At Chemfab Alkalis (NSE:CHEMFAB)
Aug 30Be Wary Of Chemfab Alkalis (NSE:CHEMFAB) And Its Returns On Capital
May 10Some Investors May Be Worried About Chemfab Alkalis' (NSE:CHEMFAB) Returns On Capital
Feb 02Does Chemfab Alkalis (NSE:CHEMFAB) Have A Healthy Balance Sheet?
Dec 20Returns On Capital Are Showing Encouraging Signs At Chemfab Alkalis (NSE:CHEMFAB)
Sep 27Increases to CEO Compensation Might Be Put On Hold For Now at Chemfab Alkalis Limited (NSE:CHEMFAB)
Jul 28Chemfab Alkalis (NSE:CHEMFAB) Is Doing The Right Things To Multiply Its Share Price
Jun 11Could Chemfab Alkalis Limited (NSE:CHEMFAB) Have The Makings Of Another Dividend Aristocrat?
Apr 19Is Chemfab Alkalis (NSE:CHEMFAB) Likely To Turn Things Around?
Feb 25Chemfab Alkalis (NSE:CHEMFAB) Has A Somewhat Strained Balance Sheet
Jan 18Three Things You Should Check Before Buying Chemfab Alkalis Limited (NSE:CHEMFAB) For Its Dividend
Dec 23What Do The Returns On Capital At Chemfab Alkalis (NSE:CHEMFAB) Tell Us?
Nov 27Are Chemfab Alkalis's (NSE:CHEMFAB) Statutory Earnings A Good Guide To Its Underlying Profitability?
Nov 01We Think Chemfab Alkalis (NSE:CHEMFAB) Is Taking Some Risk With Its Debt
Sep 09Here’s What’s Happening With Returns At Chemfab Alkalis (NSE:CHEMFAB)
Aug 03Is Chemfab Alkalis Limited (NSE:CHEMFAB) A Good Fit For Your Dividend Portfolio?
Jul 07In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Chemfab Alkalis has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2023 | 3,183 | 362 | N/A | N/A | N/A |
9/30/2023 | 3,159 | 440 | 118 | 694 | N/A |
6/30/2023 | 3,123 | 527 | N/A | N/A | N/A |
3/31/2023 | 3,314 | 646 | 350 | 926 | N/A |
12/31/2022 | 3,462 | 621 | N/A | N/A | N/A |
9/30/2022 | 3,400 | 592 | 606 | 808 | N/A |
6/30/2022 | 3,227 | 470 | N/A | N/A | N/A |
3/31/2022 | 2,716 | 287 | 347 | 549 | N/A |
12/31/2021 | 2,349 | 43 | N/A | N/A | N/A |
9/30/2021 | 2,034 | -66 | 340 | 413 | N/A |
6/30/2021 | 1,875 | -67 | N/A | N/A | N/A |
3/31/2021 | 1,808 | -81 | 381 | 454 | N/A |
12/31/2020 | 1,702 | 53 | N/A | N/A | N/A |
9/30/2020 | 1,753 | 96 | -199 | 424 | N/A |
6/30/2020 | 1,889 | 181 | N/A | N/A | N/A |
3/31/2020 | 2,045 | 254 | -80 | 542 | N/A |
12/31/2019 | 2,201 | 326 | N/A | N/A | N/A |
9/30/2019 | 2,126 | 336 | 36 | 567 | N/A |
6/30/2019 | 1,999 | 174 | N/A | N/A | N/A |
3/31/2019 | 1,932 | 168 | -120 | 410 | N/A |
12/31/2018 | 1,877 | 156 | N/A | N/A | N/A |
9/30/2018 | 1,892 | 162 | N/A | N/A | N/A |
6/30/2018 | 1,902 | 296 | N/A | N/A | N/A |
3/31/2018 | 1,796 | 255 | 177 | 439 | N/A |
3/31/2017 | 1,402 | 155 | N/A | 379 | N/A |
3/31/2016 | 248 | 4 | N/A | -7 | N/A |
Analyst Future Growth Forecasts
Einkommen vs. Sparrate: Unzureichende Daten, um festzustellen, ob das prognostizierte Gewinnwachstum von CHEMFAB über der Sparquote liegt (6.7%).
Ertrag vs. Markt: Unzureichende Daten, um festzustellen, ob die Gewinne von CHEMFAB schneller wachsen werden als der Markt Indian
Hohe Wachstumserträge: Die Daten reichen nicht aus, um festzustellen, ob die Einnahmen von CHEMFAB in den nächsten 3 Jahren signifikant steigen werden.
Einnahmen vs. Markt: Die Daten reichen nicht aus, um festzustellen, ob die Einnahmen von CHEMFAB schneller wachsen werden als der Markt von Indian.
Hohe Wachstumseinnahmen: Es liegen keine ausreichenden Daten vor, um festzustellen, ob die Einnahmen von CHEMFAB schneller wachsen werden als 20% pro Jahr.
Earnings per Share Growth Forecasts
Future Return on Equity
Künftige Eigenkapitalrendite: Unzureichende Daten, um festzustellen, ob die Eigenkapitalrendite von CHEMFAB in 3 Jahren voraussichtlich hoch sein wird